Compounds of Formula (I)
inhibit the PARP enzyme and are useful for treating a disease or a disorder associated with PARP. Also disclosed are pharmaceutical compositions comprising compounds of Formula (I), methods of treatment comprising compounds of Formula (I), and methods of inhibiting the PARP enzyme comprising compounds of Formula (I).
Compounds of Formula (I) inhibit the PARP enzyme and are useful for treating a disease or a disorder associated with PARP. Also disclosed are pharmaceutical compositions comprising compounds of Formula (I), methods of treatment comprising compounds of Formula (I), and methods of inhibiting the PARP enzyme comprising compounds of Formula (I).
Identification of ring-fused pyrazolo pyridin-2-ones as novel poly(ADP-ribose)polymerase-1 inhibitors
作者:Wilna J. Moree、Phyllis Goldman、Anthony J. Demaggio、Erik Christenson、Dan Herendeen、John Eksterowicz、Edward A. Kesicki、David L. McElligott、Graham Beaton
DOI:10.1016/j.bmcl.2008.07.091
日期:2008.9
A novel class of PARP-1 inhibitors was identified containing a non-aromatic heterocycle or carbocycle fused to a pyrazolo pyridin-2-one. Compounds displayed low nanomolar binding activity in the PARP-1 binding assay and submicromolar activity in a cell based chemosensitization assay. (C) 2008 Elsevier Ltd. All rights reserved.
New pyrazolo(3,4-b)pyridine derivatives and process for producing them